 The purpose of this study is to examine the efficacy of escitalopram compared to placebo in reducing Acute Stress Disorder ASD symptoms and in preventing the emergence of Post-Traumatic Stress Disorder PTSD in patients with medical trauma who are at risk for the development of PTSD based on the presence of ASD symptoms. 